tert-butyl ((1R,3S)-3-(aminomethyl)cyclohexyl)carbamate

Catalog No.: 
ACMUXY026
CAS No.: 
2140264-95-3
Molecular Formula: 
C12H24N2O2
Molecular Weight: 
228.34
tert-butyl ((1R,3S)-3-(aminomethyl)cyclohexyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$294.00InquiryInquiry
250mg98%$470.00InquiryInquiry
1g98%$1174.00InquiryInquiry
5g98%$3524.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-butyl ((1R,3S)-3-(aminomethyl)cyclohexyl)carbamate
IUPAC Nametert-butyl ((1R,3S)-3-(aminomethyl)cyclohexyl)carbamate
Molecular FormulaC12H24N2O2
Molecular Weight228.34
SMILESCC(C)(C)OC(=O)N[C@@H]1CCC[C@H](CN)C1
InChI KeyOJNXXJZVUYXMLE-VHSXEESVSA-N
Synonymtert-butyl N-[(1R,3S)-3-(aminomethyl)cyclohexyl]carbamate;Carbamic acid,N-[(1R,3S)-3-(aminomethyl)cyclohexyl]-, 1,1-dimethylethyl ester;tert-butyl ((1r,3s)-3-(aminomethyl)cyclohexyl)carbamate
CAS No.2140264-95-3

Safety Data

Pictogram
PICTURE
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACMUXY026 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMUXY026 route product structure diagram
    ACMUXY0262140264-95-3
Inquiry

2. ACMUXY026 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMUXY026 route product structure diagram
    ACMUXY0262140264-95-3
Inquiry

3. ACMUXY026 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMUXY026 route product structure diagram
    ACMUXY0262140264-95-3
Inquiry

Comments (0)